FDA Clears FluChip-8G Influenza A+B Assay
The multiplexed assay can positively characterize and differentiate a wide variety of influenza A virus strains as seasonal or nonseasonal, with same-day results.
Read MorePosted by Chaunie Brusie | Jun 21, 2019 | Microarray Systems, Software |
The multiplexed assay can positively characterize and differentiate a wide variety of influenza A virus strains as seasonal or nonseasonal, with same-day results.
Read MorePosted by Chaunie Brusie | Jun 20, 2019 | Research, Storage |
Partnering universities and companies in Europe and the United States have developed a hybrid Cloud-based platform for fast and cost-efficient whole-genome sequencing and analysis.
Read MorePosted by Chaunie Brusie | Jun 20, 2019 | Breast |
The iGAP registry will capture information regarding breast cancer risk assessment, genetic testing utilization, and the impact of genetic information on treatment practices and patient outcomes.
Read MorePosted by Chaunie Brusie | Jun 10, 2019 | Cytology, Slides |
The New York State Department of Health has approved the performance of ThyraMir testing on samples presented via cytology slides, FFPE-fixed tissue specimens, or fine needle aspirates.
Read MorePosted by Steve Halasey | May 27, 2019 | Research |
A retrospective study found that PacBio’s SMRT sequencing identified superior HLA matches, which are critical for determining successful transplant outcomes.
Read More